Establishment and characterization of NS3 protein-specific T-cell clones from a patient with chronic hepatitis C
Tóm tắt
Our previous study showed dominant proliferative response of peripheral mononuclear cells to hepatitis C virus (HCV) nonstructural (NS-3) (T9, from aa 1188 to 1493) in chronically infected patients. Six T9-specific T-cell clones derived in an HCV patient were established and studied for the antigen specificity and the ability of augmentation of in vitro antibody production. All these cloned T-cell lines responded exclusively to T9 antigen and could help autologous B cells in producing anti-T9 antibody in vitro. Cytokine mRNAs of these T cells was detected by polymerase chain reaction and predominant IL-2 and IFN-γ production was noted. In addition, further elucidation of T-cell antigenic determinant and MHC restriction suggested that these T-cell clones recognized at least two different T-cell antigenic determinants within the NS-3 region in an HLA DQ2-restricted manner. We believe characterization of HCV-specific T-cell responses, especially T-cell epitope mapping and cytokine production pattern, may shed light on further understanding the pathogenic mechanism and designing therapy for HCV infection.
Tài liệu tham khảo
Alter HJ. The hepatitis C virus and its relationship to the clinical spectrum of NANB hepatitis. J Gastroenterol Hepatol 1(suppl):78–94;1990.
Bartenschlager R, Ahlborn-Laake L, Mous J, Jacobsen H. Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. J Virol 67:3835–3844;1993.
Bertoletti A, Sette A, Chisari FV, et al. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369:407–410;1994.
Biron CA. Cytokines in the generation of immune responses to, and resolution of, virus infection. Current Opin Immunol 6:530–538;1994.
Botarelli P, Brunetto MR, Miuntello MA, et al. T-lymphocyte response to hepatitis C virus in different clinical course of infection. Gastroenterology 104:580–587;1993.
Chen D-S, Kuo G, Sung J-L, et al. Hepatitis C virus infection in the area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis 162:817–822;1990.
Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359–362;1989.
Chromczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159;1987.
Clerici M, Hakim FT, Venzon DJ, et al. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest 91:759–765;1993.
Clerici M, Shearer GM. The Th1–Th2 hypothesis of HIV infection: new insights. Immunol Today 15:575–581;1994.
Diepolder HM, Zachoval R, Hoffmann RM. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346:1006–1007;1995.
Farci P, Alter HJ, Govindarajan S, et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 258:135–140;1992.
Ferrari C, Valli A, Galati L, et al. T-cell response to structural and nonstructural hepatitis C virus antigenic in persistent and self-limited hepatitis C virus infection. Hepatology 19:286–295;1994.
Hwang L-H, Yang P-M, Lai M-Y, et al. Identification of humoral antigenic determinants within the hepatitis C virus NS3 protein. J Infect Dis 174:173–176;1996.
Koziel MJ, Dudely D, Wong JT, et al. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 149:3339–3344;1992.
Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362–364;1989.
Miyamura T, Saito I, Katayama S, et al. Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: Application to diagnosis and blood screening for posttransfusion hepatitis. Proc Natl Acad Sci USA 87:983–987;1990.
Mosely JW, Aach RD, Hollinger FB, et al. Non-A, non-B hepatitis and antibody to hepatitis C virus. J Am Med Assoc 263:77–78:1990.
Nakatsuji Y, Matsumoto A, Tanaka E, et al. Detection of chronic hepatitis C virus infection by four diagnostic systems: first-generation and second-generation recombinant immunoblot assay and nested polymerase chain reaction analysis. Hepatology 16:300–305;1992.
Nasoff MS, Zebedee SL, Inchauspe G, Prince AM. Identification of an immunodominant epitope within the capsid protein of hepatitis C virus. Proc Natl Acad Sci USA 88:5462–5466;1991.
Okamoto H, Sugiyama Y, Okada S, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. J Gen Virol 73:673–679;1992.
Okamoto H, Kurai K, Okada S, et al. Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: Comparative study of four distinct genotypes. Virology 188:331–341;1992.
Powrie F, Mason D. Phenotypic and functional heterogeneity of CD4+ T cells. Immunol Today 9:274–277;1988.
Reed SG, Scott P. T-cell and cytokine responses in leishmaniasis. Current Opin Immunol 5:524–531;1993.
Schupper H, Hayashi P, Scheffel J, et al. Peripheral-blood mononuclear cell response to recombinant hepatitis C virus antigens in patients with chronic hepatitis C. Hepatology 18:1055–1060;1993.
Shirai M, Okada H, Nishioka M. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. J Virol 68:3334–3342;1994.
Tomai L, Failla C, Santolini E, De Francesco R, La Monica N. NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J Virol 67:4017–4026;1993.
Weiner AJ, Geysen HM, Christopherson C, et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infection. Proc Natl Acad Sci USA 89:3468–3472;1992.
Yang P-M, Hwang L-H, Lai M-Y, et al. Prominent proliferative response of peripheral blood mononuclear cells to a recombinant nonstructrual (NS3) protein of hepatitis virus in patients with chronic hepatitis C. Clin Exp Immunol 101:272–277;1995.